Success Metrics

Active Trials
4(44%)

Phase Distribution

Ph phase_3
5
56%
Ph not_applicable
1
11%
Ph phase_1
1
11%
Ph phase_2
1
11%

Phase Distribution

1

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
5(62.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

9

all time

Status Distribution
Active(9)

Detailed Status

Not yet recruiting5
Recruiting4

Development Timeline

Analytics

Development Status

Total Trials
9
Active
4
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 11 (12.5%)
Phase 21 (12.5%)
Phase 35 (62.5%)
N/A1 (12.5%)

Trials by Status

not_yet_recruiting556%
recruiting444%

Recent Activity

4 active trials
Showing 5 of 9
recruitingphase_1

A Clinical Study of Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

NCT07338487
not_yet_recruitingphase_3

Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer

NCT07477808
recruitingphase_3

Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer

NCT07150663
not_yet_recruitingphase_2

Nano-crystalline Megestrol Acetate for Anorexia-Cachexia Syndrome in Advanced Lung Cancer

NCT07092137
not_yet_recruitingphase_3

Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia Phase

NCT06961201
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07338487Phase 1

A Clinical Study of Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

Recruiting
NCT07477808Phase 3

Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer

Not Yet Recruiting
NCT07150663Phase 3

Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer

Recruiting
NCT07092137Phase 2

Nano-crystalline Megestrol Acetate for Anorexia-Cachexia Syndrome in Advanced Lung Cancer

Not Yet Recruiting
NCT06961201Phase 3

Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia Phase

Not Yet Recruiting
NCT06961188Phase 3

Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis

Not Yet Recruiting
NCT06940102

Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors

Recruiting
NCT06830018Not Applicable

Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related Fatigue

Recruiting
NCT06772428Phase 3

Nano-crystalline Megestrol Acetate for Adjuvant Treatment in High-risk Head and Neck Squamous Cell Carcinoma After Surgery.

Not Yet Recruiting

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9